073326192	073326192	CD	B-NP	O
|	|	NN	I-NP	O
CMC	CMC	NN	I-NP	O
|	|	NN	I-NP	O
03120454	03120454	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2229883	2229883	CD	B-NP	O
|	|	CC	I-NP	O
11/2/2003	11/2/2003	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
AORTIC	AORTIC	NNP	I-NP	I-protein
STENOSIS	STENOSIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/21/2003	4/21/2003	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/3/2003	7/3/2003	CD	B-NP	O
ADMITTING	ADMITTING	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
MITRAL	MITRAL	JJ	B-NP	O
REGURGITATION	REGURGITATION	NN	I-NP	O
AND	AND	CC	I-NP	O
MILD	MILD	NN	I-NP	O
AORTIC	AORTIC	NN	I-NP	O
STENOSIS	STENOSIS	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
An	An	DT	B-NP	O
80-year-old	80-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
known	known	JJ	B-NP	O
rheumatic	rheumatic	JJ	I-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
mitral	mitral	JJ	B-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
paroxysmal	paroxysmal	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
underwent	undergo	VBD	B-VP	O
an	an	DT	B-NP	O
AV	AV	NN	I-NP	O
ablation	ablation	NN	I-NP	O
and	and	CC	O	O
post	post	NN	B-NP	O
ablation	ablation	NN	I-NP	O
requiring	require	VBG	B-VP	O
a	a	DT	B-NP	O
permanent	permanent	JJ	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
now	now	RB	B-ADVP	O
complains	complain	VBZ	B-VP	O
about	about	IN	B-PP	O
progressive	progressive	JJ	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
ankle	ankle	NN	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
referred	refer	VBN	B-VP	O
for	for	IN	B-PP	O
surgery	surgery	NN	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Past	Past	NNP	B-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
is	be	VBZ	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
venous	venous	JJ	B-NP	O
stasis	stasis	NN	I-NP	O
changes	change	NNS	I-NP	O
with	with	IN	B-PP	O
ankle	ankle	NN	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
mitral	mitral	JJ	B-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
mild	mild	JJ	B-NP	O
aortic	aortic	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
rheumatic	rheumatic	JJ	B-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
,	,	,	O	O
AV	AV	NN	B-NP	O
nodal	nodal	JJ	I-NP	O
ablation	ablation	NN	I-NP	O
as	as	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
above	above	IN	B-PP	O
requiring	require	VBG	B-VP	O
permanent	permanent	JJ	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
pain	pain	NN	I-NP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
heel	heel	NN	I-NP	O
,	,	,	O	O
degenerative	degenerative	JJ	B-NP	O
joint	joint	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NN	B-NP	O
SURGICAL	SURGICAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Past	Past	NN	B-NP	O
surgical	surgical	JJ	I-NP	O
history	history	NN	I-NP	O
is	be	VBZ	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
right	right	JJ	B-NP	O
knee	knee	NN	I-NP	O
surgery	surgery	NN	I-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
hip	hip	NN	I-NP	O
replacement	replacement	NN	I-NP	O
in	in	IN	B-PP	O
2002	2002	CD	B-NP	O
,	,	,	O	O
appendectomy	appendectomy	NN	B-NP	O
,	,	,	O	O
hernia	hernia	NN	B-NP	O
repair	repair	NN	I-NP	O
,	,	,	O	O
AV	AV	NN	B-NP	O
ablation	ablation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
permanent	permanent	JJ	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
significant	significant	JJ	I-NP	O
family	family	NN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
tobacco	tobacco	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Penicillin	Penicillin	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
no	no	DT	B-NP	O
reaction	reaction	NN	I-NP	O
documented	document	VBD	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Toprol	Toprol	NN	B-NP	O
60	60	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
once	once	RB	I-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
4	4	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
furosemide	furosemide	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
once	once	RB	I-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Levoxyl	Levoxyl	NN	B-NP	O
50	50	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Protonix	Protonix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
once	once	RB	I-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
propoxyphene	propoxyphene	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
multivitamin	multivitamin	NN	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAM	EXAM	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	O
of	of	IN	B-PP	O
96.1	96.1	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
70	70	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
120/60	120/60	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
arm	arm	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
PERRLA	PERRLA	NN	B-NP	O
,	,	,	O	O
dentition	dentition	NN	B-NP	O
without	without	IN	B-PP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
carotid	carotid	NN	I-NP	O
bruits	bruit	NNS	I-NP	O
.	.	.	O	O

CHEST	CHEST	NN	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
incision	incision	NN	I-NP	O
.	.	.	O	O

CARDIOVASCULAR	CARDIOVASCULAR	NN	B-NP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
with	with	IN	B-PP	O
also	also	RB	B-ADVP	O
a	a	DT	B-NP	O
diastolic	diastolic	JJ	I-NP	O
rumble	rumble	NN	I-NP	O
component	component	NN	I-NP	O
,	,	,	O	O
pulses	pulse	VBZ	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	B-NP	O
throughout	throughout	IN	B-ADVP	O
.	.	.	O	O

RESPIRATORY	RESPIRATORY	NN	B-NP	O
:	:	:	O	O
Rales	Rale	NNS	B-NP	O
present	present	VBP	B-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Does	Do	VBZ	B-VP	O
not	not	RB	I-VP	O
indicate	indicate	VB	I-VP	O
how	how	WRB	B-ADVP	O
far	far	RB	I-ADVP	O
up	up	IN	B-ADVP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Cyst	Cyst	NN	B-NP	O
palpable	palpable	JJ	I-NP	O
liver	liver	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
mass	mass	NN	I-NP	O
noted	note	VBD	B-VP	O
,	,	,	O	O
soft	soft	JJ	B-ADJP	O
.	.	.	O	O

RECTAL	RECTAL	NN	B-NP	O
:	:	:	O	O
Deferred	Defer	VBN	B-VP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
bilateral	bilateral	JJ	B-NP	O
venous	venous	JJ	I-NP	O
stasis	stasis	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
active	active	JJ	B-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

NEURO	NEURO	NN	B-NP	B-protein
:	:	:	O	O
Alert	Alert	NNP	B-NP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
,	,	,	O	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
focal	focal	JJ	I-NP	O
deficits	deficit	NNS	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
VALUES	VALUES	VBZ	B-VP	O
ON	ON	NN	B-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
of	of	IN	B-PP	O
141	141	CD	B-NP	O
,	,	,	O	O
K	K	NN	B-NP	O
of	of	IN	B-PP	O
4.5	4.5	CD	B-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
of	of	IN	B-PP	O
105	105	CD	B-NP	O
,	,	,	O	O
CO2	CO2	NN	B-NP	B-protein
of	of	IN	B-PP	O
26	26	CD	B-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	O
of	of	IN	B-PP	O
32	32	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
1.2	1.2	CD	B-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
of	of	IN	B-PP	O
110	110	CD	B-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
of	of	IN	B-PP	O
2.2	2.2	CD	B-NP	O
.	.	.	O	O

HEMATOLOGY	HEMATOLOGY	NN	B-NP	O
:	:	:	O	O
White	White	JJ	B-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
7.5	7.5	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
of	of	IN	B-PP	O
32.3	32.3	CD	B-NP	O
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
of	of	IN	B-PP	O
216	216	CD	B-NP	O
,	,	,	O	O
PT	PT	NN	B-NP	O
of	of	IN	B-PP	O
13	13	CD	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
INR	INR	NN	I-NP	B-protein
of	of	IN	B-PP	O
1.1	1.1	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
PTT	PTT	NN	I-NP	O
of	of	IN	B-PP	O
59.3	59.3	CD	B-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
on	on	IN	B-PP	O
6/12/03	6/12/03	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
30	30	CD	I-NP	O
%	%	NN	I-NP	O
proximal	proximal	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
dominant	dominant	JJ	I-NP	O
circulation	circulation	NN	I-NP	O
,	,	,	O	O
ventriculogram	ventriculogram	NN	B-NP	O
of	of	IN	B-PP	O
49	49	CD	B-NP	O
,	,	,	O	O
PA	PA	NN	B-NP	O
mean	mean	NN	I-NP	O
of	of	IN	B-PP	O
30	30	CD	B-NP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
capillary	capillary	JJ	I-NP	O
wedge	wedge	NN	I-NP	O
of	of	IN	B-PP	O
15	15	CD	B-NP	O
,	,	,	O	O
cardiac	cardiac	JJ	B-NP	O
output	output	NN	I-NP	O
of	of	IN	B-PP	O
3.7	3.7	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
cardiac	cardiac	JJ	B-NP	O
index	index	NN	I-NP	O
of	of	IN	B-PP	O
2.2	2.2	CD	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Cardiac	Cardiac	NNP	I-NP	O
Surgery	Surgery	NNP	I-NP	O
Service	Service	NNP	I-NP	O
on	on	IN	B-PP	O
6/12/03	6/12/03	CD	B-NP	O
,	,	,	O	O
needed	need	VBD	B-VP	O
a	a	DT	B-NP	O
pre-op	pre-op	JJ	I-NP	O
echo	echo	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
on	on	IN	B-PP	O
7/7/03	7/7/03	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
mild	mild	JJ	B-NP	O
LV	LV	NN	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
with	with	IN	B-PP	O
preserved	preserve	VBN	B-NP	O
overall	overall	JJ	I-NP	O
systolic	systolic	JJ	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
EF	EF	NN	B-NP	O
of	of	IN	B-PP	O
about	about	RB	B-NP	O
55	55	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
right	right	JJ	B-NP	O
ventricle	ventricle	NN	I-NP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
size	size	NN	I-NP	O
and	and	CC	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
aortic	aortic	JJ	B-NP	O
valve	valve	NN	I-NP	O
mildly	mildly	RB	B-VP	O
thickened	thicken	VBN	I-VP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
leaflet	leaflet	NN	B-NP	O
excursion	excursion	NN	I-NP	O
is	be	VBZ	B-VP	O
good	good	JJ	B-ADJP	O
,	,	,	O	O
the	the	DT	B-NP	O
peak	peak	JJ	I-NP	O
transaortic	transaortic	JJ	I-NP	O
velocity	velocity	NN	I-NP	O
is	be	VBZ	B-VP	O
2	2	CD	B-NP	O
mm	mm	NN	I-NP	O
per	per	IN	B-PP	O
second	second	JJ	B-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
peak	peak	NN	I-NP	O
instantaneous	instantaneous	JJ	I-NP	O
gradient	gradient	NN	I-NP	O
of	of	IN	B-PP	O
60	60	CD	B-NP	O
mmHg	mmHg	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
mitral	mitral	JJ	I-NP	O
annulus	annulus	NN	I-NP	O
is	be	VBZ	B-VP	O
thickened	thicken	VBN	I-VP	O
and	and	CC	I-VP	O
calcified	calcify	VBN	I-VP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
mild	mild	JJ	B-ADJP	O
to	to	TO	B-PP	O
moderate	moderate	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
peak	peak	JJ	I-NP	O
antegrade	antegrade	NN	I-NP	O
mitral	mitral	JJ	I-NP	O
velocity	velocity	NN	I-NP	O
is	be	VBZ	B-VP	O
1.8	1.8	CD	B-NP	O
,	,	,	O	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
maximal	maximal	JJ	I-NP	O
gradient	gradient	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
valve	valve	JJ	I-NP	O
area	area	NN	I-NP	O
is	be	VBZ	B-VP	O
estimated	estimate	VBN	I-VP	O
at	at	IN	B-PP	O
approximately	approximately	RB	B-NP	O
1.8	1.8	CD	I-NP	O
cm2	cm2	NN	I-NP	O
.	.	.	O	O

Mild	Mild	JJ	B-NP	O
tricuspid	tricuspid	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
regurgitant	regurgitant	JJ	I-NP	O
velocity	velocity	NN	I-NP	O
of	of	IN	B-PP	O
2.5	2.5	CD	B-NP	O
,	,	,	O	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
systolic	systolic	JJ	I-NP	O
pressures	pressure	NNS	I-NP	O
.	.	.	O	O

Due	Due	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
nonhealing	nonhealing	JJ	I-NP	O
ulcer	ulcer	NN	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
evaluated	evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
Derm	Derm	NN	B-NP	O
for	for	IN	B-PP	O
over	over	IN	B-NP	O
a	a	DT	I-NP	O
year	year	NN	I-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
Vascular	Vascular	NNP	B-NP	O
Surgery	Surgery	NNP	I-NP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
for	for	IN	B-PP	O
vascular	vascular	JJ	B-NP	O
compromise	compromise	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
nonhealing	nonhealing	JJ	I-NP	O
ulcers	ulcer	NNS	I-NP	O
.	.	.	O	O

ABIs	ABI	NNS	B-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
both	both	CC	O	O
left	left	JJ	B-NP	O
and	and	CC	I-NP	O
right	right	JJ	I-NP	O
ABIs	ABI	NNS	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
PVRs	PVR	NNS	B-NP	B-protein
were	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
vascular	vascular	JJ	I-NP	B-protein
component	component	NN	I-NP	I-protein
to	to	TO	B-PP	O
these	these	DT	B-NP	O
nonhealing	nonhealing	JJ	I-NP	O
ulcers	ulcer	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
they	they	PRP	B-NP	O
recommended	recommend	VBD	B-VP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
venous	venous	JJ	B-NP	O
stasis	stasis	NN	I-NP	O
changes	change	NNS	I-NP	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
edema	edema	NN	I-NP	O
and	and	CC	O	O
felt	feel	VBD	B-VP	O
local	local	JJ	B-NP	O
wound	wound	NN	I-NP	O
care	care	NN	I-NP	O
and	and	CC	O	O
leg	leg	NN	B-NP	O
elevation	elevation	NN	I-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
choice	choice	NN	B-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
point	point	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
poor	poor	JJ	B-NP	O
dentition	dentition	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Dental	Dental	NNP	I-NP	O
Team	Team	NNP	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
active	active	JJ	B-NP	O
infection	infection	NN	I-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
that	that	WDT	B-NP	O
needed	need	VBD	B-VP	O
further	further	JJ	B-NP	O
dental	dental	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
surgery	surgery	NN	I-NP	O
.	.	.	O	O

Due	Due	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
plan	plan	NN	I-NP	O
for	for	IN	B-PP	O
valve	valve	NN	B-NP	O
replacement	replacement	NN	I-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
was	be	VBD	B-VP	O
empirically	empirically	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Flagyl	Flagyl	NN	B-NP	O
for	for	IN	B-PP	O
coverage	coverage	NN	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
nonhealing	nonhealing	JJ	I-NP	O
ulcers	ulcer	NNS	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
Dermatology	Dermatology	NNP	B-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
felt	feel	VBD	B-VP	O
these	these	DT	B-NP	O
were	be	VBD	B-VP	O
venous	venous	JJ	B-NP	O
stasis	stasis	NN	I-NP	O
ulcers	ulcer	NNS	I-NP	O
and	and	CC	O	O
recommended	recommend	VBD	B-VP	O
Hibiclens	Hibiclens	NNP	B-NP	O
wash	wash	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Silvadene	Silvadene	NN	B-NP	O
dressing	dress	VBG	B-VP	O
with	with	IN	B-PP	O
Xeroform	Xeroform	NN	B-NP	O
gauze	gauze	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
leg	leg	NN	B-NP	O
elevation	elevation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
recommended	recommend	VBD	B-VP	O
lower	low	JJR	B-NP	O
noninvasive	noninvasive	JJ	I-NP	O
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
DVT	DVT	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
on	on	IN	B-PP	O
4/25/03	4/25/03	CD	B-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
DVT	DVT	NN	B-NP	B-protein
.	.	.	O	O

On	On	IN	B-PP	O
8/11	8/11	CD	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
down	down	RP	B-PRT	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
operating	operating	NN	I-NP	O
room	room	NN	I-NP	O
and	and	CC	O	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
mitral	mitral	JJ	I-NP	O
valve	valve	NN	I-NP	O
replacement	replacement	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
preservation	preservation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
posterior	posterior	JJ	I-NP	O
mitral	mitral	JJ	I-NP	O
leaflet	leaflet	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
Hancock	Hancock	NNP	I-NP	O
porcine	porcine	JJ	I-NP	O
valve	valve	NN	I-NP	O
placed	place	VBN	B-VP	O
.	.	.	O	O

Total	Total	JJ	B-NP	O
cardiopulmonary	cardiopulmonary	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
126	126	CD	B-NP	O
minutes	minute	NNS	I-NP	O
.	.	.	O	O

Cross-clamp	Cross-clamp	JJ	B-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
89	89	CD	B-NP	O
minutes	minute	NNS	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
came	come	VBD	B-VP	O
off	off	IN	B-PP	O
the	the	DT	B-NP	O
heart-lung	heart-lung	JJ	I-NP	O
machine	machine	NN	I-NP	O
on	on	IN	B-PP	O
Levophed	Levophed	NNP	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
paced	pace	VBN	I-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
internal	internal	JJ	I-NP	O
pacer	pacer	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
some	some	DT	B-NP	O
IV	IV	CD	I-NP	O
amiodarone	amiodarone	NN	I-NP	O
for	for	IN	B-PP	O
uncontrolled	uncontrolled	JJ	B-NP	O
A	A	NN	I-NP	O
fib	fib	NN	I-NP	O
immediately	immediately	RB	B-VP	O
coming	come	VBG	I-VP	O
off	off	IN	B-PP	O
the	the	DT	B-NP	O
heart-lung	heart-lung	JJ	I-NP	O
machine	machine	NN	I-NP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
few	few	JJ	I-NP	O
hours	hour	NNS	I-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
had	have	VBD	B-VP	O
frequent	frequent	JJ	B-NP	O
ectopy	ectopy	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
pacer	pacer	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
Cardiology	Cardiology	NNP	I-NP	O
Team	Team	NNP	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
.	.	.	O	O

With	With	IN	B-PP	O
interrogation	interrogation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pacer	pacer	NN	I-NP	O
,	,	,	O	O
they	they	PRP	B-NP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
having	have	VBG	I-VP	O
frequent	frequent	JJ	B-NP	O
infranodal	infranodal	JJ	I-NP	O
ectopy	ectopy	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
pacer	pacer	NN	I-NP	O
itself	itself	PRP	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
AV	AV	NN	I-NP	O
function	function	NN	I-NP	O
was	be	VBD	B-VP	O
functioning	function	VBG	I-VP	O
normally	normally	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
AF	AF	NN	I-NP	O
suppression	suppression	NN	I-NP	O
was	be	VBD	B-VP	O
temporarily	temporarily	RB	I-VP	O
turned	turn	VBN	I-VP	O
off	off	RP	B-PRT	O
,	,	,	O	O
which	which	WDT	B-NP	O
they	they	PRP	B-NP	O
felt	feel	VBD	B-VP	O
may	may	MD	B-VP	O
stabilize	stabilize	VB	I-VP	O
the	the	DT	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
decrease	decrease	VB	B-VP	O
the	the	DT	B-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
ectopy	ectopy	NN	B-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
monitor	monitor	NN	I-NP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
several	several	JJ	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
amiodarone	amiodarone	NN	I-NP	O
drip	drip	NN	I-NP	O
had	have	VBD	B-VP	O
better	good	JJR	B-NP	O
rate	rate	NN	I-NP	O
control	control	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
suppression	suppression	NN	B-NP	O
of	of	IN	B-PP	O
also	also	RB	B-ADVP	O
the	the	DT	B-NP	O
intrinsic	intrinsic	JJ	I-NP	O
A	A	NN	I-NP	O
fib	fib	NN	I-NP	O
that	that	IN	B-NP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
preoperatively	preoperatively	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
on	on	IN	B-PP	O
post-op	post-op	JJ	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
3	3	CD	I-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
over	over	RP	B-PRT	O
to	to	TO	B-PP	O
Lopressor	Lopressor	NN	B-NP	O
from	from	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
,	,	,	O	O
per	per	IN	B-PP	O
recommendation	recommendation	NN	B-NP	O
of	of	IN	B-PP	O
Cardiology	Cardiology	NNP	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
extubated	extubate	VBN	I-VP	O
on	on	IN	B-PP	O
post-op	post-op	JJ	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
required	require	VBN	B-VP	O
heavy	heavy	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
several	several	JJ	I-NP	O
days	day	NNS	I-NP	O
to	to	TO	B-VP	O
wean	wean	VB	I-VP	O
off	off	RP	B-PRT	B-protein
her	her	PRP$	B-NP	O
O2	O2	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
by	by	IN	B-PP	O
day	day	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
was	be	VBD	B-VP	O
weaned	wean	VBN	I-VP	O
off	off	RP	B-PRT	O
O2	O2	NN	B-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
looked	look	VBD	B-VP	O
slightly	slightly	RB	B-ADJP	O
wet	wet	JJ	I-ADJP	O
,	,	,	O	O
so	so	IN	O	O
patient	patient	NN	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
on	on	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
rehab	rehab	NN	I-NP	O
center	center	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
improvement	improvement	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
venous	venous	JJ	I-NP	O
stasis	stasis	NN	I-NP	O
ulcers	ulcer	NNS	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
they	they	PRP	B-NP	O
are	be	VBP	B-VP	O
still	still	RB	B-ADVP	O
open	open	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
with	with	IN	B-PP	O
discussion	discussion	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Cardiac	Cardiac	NNP	I-NP	O
Surgery	Surgery	NNP	I-NP	O
chief	chief	NN	I-NP	O
fellow	fellow	NN	I-NP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
discussed	discuss	VBN	I-VP	O
that	that	IN	B-SBAR	O
until	until	IN	B-SBAR	O
they	they	PRP	B-NP	O
were	be	VBD	B-VP	O
healed	heal	VBN	I-VP	O
with	with	IN	B-PP	O
new	new	JJ	B-NP	O
valves	valve	NNS	I-NP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
that	that	IN	B-SBAR	O
they	they	PRP	B-NP	O
would	would	MD	B-VP	O
like	like	VB	I-VP	O
to	to	TO	I-VP	O
continue	continue	VB	I-VP	O
the	the	DT	B-NP	O
triple	triple	JJ	I-NP	O
antibiotics	antibiotic	NNS	I-NP	O
of	of	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Flagyl	Flagyl	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
rehab	rehab	NN	I-NP	O
with	with	IN	B-PP	O
those	those	DT	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
as	as	IN	B-PP	O
p.o.	p.o.	NN	B-NP	O
and	and	CC	I-NP	O
vancomycin	vancomycin	NN	I-NP	O
as	as	IN	B-PP	O
IV	IV	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
PICC	PICC	NN	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
placed	place	VBN	B-VP	O
for	for	IN	B-PP	O
poor	poor	JJ	B-NP	O
venous	venous	JJ	I-NP	O
access	access	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
by	by	IN	B-PP	O
x-ray	x-ray	NN	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
good	good	JJ	B-NP	O
position	position	NN	I-NP	O
and	and	CC	O	O
43	43	CD	B-NP	O
cm	cm	NN	I-NP	O
in	in	IN	B-PP	O
length	length	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
by	by	IN	B-PP	O
post-op	post-op	JJ	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
10	10	CD	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
rehab	rehab	NN	I-NP	O
facility	facility	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
medications	medication	NNS	I-NP	O
:	:	:	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
constipation	constipation	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
x	x	SYM	B-NP	O
5	5	CD	B-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
reassess	reassess	VB	I-VP	O
further	further	RBR	B-NP	O
Lasix	Lasix	NNP	I-NP	O
dosing	dosing	NN	I-NP	O
,	,	,	O	O
ibuprofen	ibuprofen	NN	B-NP	O
200-800	200-800	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.4-6h	q.4-6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
pain	pain	NN	B-NP	O
,	,	,	O	O
Levoxyl	Levoxyl	NN	B-NP	O
50	50	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Lopressor	Lopressor	NNP	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Flagyl	Flagyl	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
until	until	IN	B-PP	O
improvement	improvement	NN	B-NP	O
of	of	IN	B-PP	O
leg	leg	NN	B-NP	O
ulcer	ulcer	NN	I-NP	O
,	,	,	O	O
Niferex	Niferex	NNP	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Darvocet	Darvocet	NNP	B-NP	O
100	100	CD	I-NP	O
one	one	CD	I-NP	O
tablet	tablet	NN	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
pain	pain	NN	B-NP	O
,	,	,	O	O
Silvadene	Silvadene	NN	B-NP	O
1	1	CD	I-NP	O
%	%	NN	I-NP	O
topical	topical	JJ	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
venous	venous	JJ	I-NP	O
stasis	stasis	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
,	,	,	O	O
vancomycin	vancomycin	NN	B-NP	O
1	1	CD	I-NP	O
g	g	NN	I-NP	O
q.	q.	NN	I-NP	O
12h	12h	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	JJ	B-NP	O
hold	hold	NN	I-NP	O
for	for	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
trough	trough	NN	I-NP	O
>	>	SYM	B-NP	O
15	15	CD	I-NP	O
-RRB-	-RRB-	SYM	B-NP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
check	check	VB	I-VP	O
with	with	IN	B-PP	O
hold	hold	NN	B-NP	O
q.d.	q.d.	NN	I-NP	O
to	to	TO	B-VP	O
target	target	VB	I-VP	O
INR	INR	NN	B-NP	B-protein
between	between	IN	B-PP	O
2	2	CD	B-NP	O
to	to	TO	B-PP	O
3	3	CD	B-NP	O
,	,	,	O	O
Coumadin	Coumadin	NNP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
dose	dose	NN	I-NP	O
tonight	tonight	NN	I-NP	O
,	,	,	O	O
K-Dur	K-Dur	NN	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
x	x	SYM	B-VP	O
5	5	CD	B-NP	O
days	day	NNS	I-NP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
current	current	JJ	I-NP	O
Lasix	Lasix	NNP	I-NP	O
dosing	dosing	NN	I-NP	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
once	once	RB	I-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Carraklenz	Carraklenz	NNP	B-NP	O
one	one	CD	I-NP	O
application	application	NN	I-NP	O
topical	topical	JJ	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
dressing	dress	VBG	B-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Lausier	Lausier	NNP	I-NP	O
,	,	,	O	O
phone	phone	NN	B-NP	O
number	number	NN	I-NP	O
099-573-0195	099-573-0195	CD	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
1-2	1-2	CD	B-NP	O
weeks	week	NNS	I-NP	O
;	;	:	O	O
patient	patient	NN	B-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Huslander	Huslander	NNP	I-NP	O
,	,	,	O	O
869-541-1864	869-541-1864	CD	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
6	6	CD	B-NP	O
weeks	week	NNS	I-NP	O
for	for	IN	B-PP	O
post	post	NN	B-NP	O
surgical	surgical	JJ	I-NP	O
eval	eval	NN	I-NP	O
;	;	:	O	O
and	and	CC	O	O
patient	patient	NN	B-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
dosing	dosing	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Na	Na	NNP	I-NP	O
,	,	,	O	O
telephone	telephone	NN	B-NP	O
number	number	NN	I-NP	O
942-088-6714	942-088-6714	CD	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
dosing	dosing	NN	I-NP	O
once	once	RB	B-VP	O
discharged	discharge	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
rehab	rehab	NN	I-NP	O
center	center	NN	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
TERRY	TERRY	NNP	B-NP	O
MENDYK	MENDYK	NNP	I-NP	O
,	,	,	O	O
P.A.	P.A.	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
TONY	TONY	NNP	B-NP	O
Q.	Q.	NNP	I-NP	O
BRENTON	BRENTON	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
QS9	QS9	NNP	I-NP	O
BO250/657851	BO250/657851	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
7327	7327	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

NLGTEW0H4J	NLGTEW0H4J	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
7/22/03	7/22/03	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
7/22/03	7/22/03	CD	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Rehab	Rehab	NNP	B-NP	O
Center	Center	NNP	I-NP	O
via	via	IN	B-PP	O
fax	fax	NN	B-NP	O
.	.	.	O	O

